DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Baselga J.
A new anti-ErbB2 strategy in the treatment of cancer: prevention of ligand-dependent ErbB2 receptor heterodimerization.
Cancer Cell 2002;
2 (02) 93-95
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.